Lisa R. Gerak
Affiliations: | Pharmacology | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Behavioral pharmacologyGoogle:
"Lisa Gerak"Mean distance: 17.14 (cluster 19) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Snyder GL, Li P, Martin T, et al. (2024) Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders. Psychopharmacology |
| Gerak LR, France CP. (2022) Attenuation of the positive-reinforcing effects of ultra-potent fentanyl analogs, along with those of fentanyl and heroin, during daily treatment with methocinnamox (MCAM) in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics |
| Gerak LR, Maguire DR, Cami-Kobeci G, et al. (2022) OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects. Behavioural Pharmacology. 33: 377-394 |
| Gray RA, Heal DJ, Maguire DR, et al. (2022) Preclinical assessment of the abuse potential of purified botanical cannabidiol: self-administration, drug discrimination, and physical dependence. The Journal of Pharmacology and Experimental Therapeutics |
| Gerak LR, France CP. (2021) Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys. Drug and Alcohol Dependence. 227: 108991 |
| France CP, Ahern G, Averick S, et al. (2020) Countermeasures for preventing and treating opioid overdose. Clinical Pharmacology and Therapeutics |
| Mada S, Gerak LR, Soyer A, et al. (2020) Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist. Psychopharmacology |
| Maguire DR, Gerak LR, Sanchez JJ, et al. (2020) Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Gerak LR, Gould GG, Daws LC, et al. (2020) Methocinnamox Produces Sustained Antagonism of the Antinociceptive Effects of Morphine and Persistent Decreases in [ 3 H]DAMGO Binding to μ Opioid Receptors in Rat Cortex The Faseb Journal. 34: 1-1 |
| Maguire DR, Gerak LR, Disney A, et al. (2020) Effects of Acute and Repeated Methocinnamox Treatment on Fentanyl Self‐administration in Rhesus Monkeys The Faseb Journal. 34: 1-1 |